THE PROSTATE CANCER FOUNDATION APPOINTS WILLIAM K. OH, MD, AS CHIEF MEDICAL OFFICER - Yahoo Finance

2 years ago 38

, /PRNewswire/ -- The Prostate Cancer Foundation (PCF), the world's starring philanthropic enactment dedicated to backing life-saving prostate crab research, contiguous announced that William K. Oh, MD, an internationally recognized genitourinary (GU) oncologist with expertise successful the usage of systemic treatments for prostate cancer, has been appointed Chief Medical Officer (CMO), a newly-created enactment position.

PCF Chief Medical Officer William K. Oh, MD

Dr. Oh joins PCF from Sema4, wherever helium served arsenic CMO of the patient-centered wellness quality institution focused connected precision medicine. He besides served for implicit a decennary arsenic Chief of the Division of Hematology and Medical Oncology astatine the Icahn School of Medicine, Ezra Greenspan Professor of Clinical Cancer Research, and Deputy Director of the NCI-designated Tisch Cancer Institute astatine Mount Sinai.

"Dr. Oh volition importantly heighten the capableness of the Prostate Cancer Foundation to not lone enactment the astir important subject successful the satellite but besides to deepen our knowing and code the challenges faced by prostate crab patients receiving attraction successful clinics and hospitals crossed the globe," says PCF President and CEO Charles J. Ryan, MD. "In his relation arsenic Chief Medical Officer, Dr. Oh volition beryllium a cardinal person of the PCF arsenic it works towards its ngo of reducing decease and suffering from prostate crab worldwide."

A postgraduate of Yale College, Dr. Oh received his MD from New York University School of Medicine. He completed his internship and residency successful interior medicine astatine Brigham and Women's Hospital successful Boston and completed his aesculapian oncology fellowship astatine the Dana-Farber Cancer Institute. Dr. Oh was astatine the Dana-Farber Cancer Institute and Harvard Medical School successful Boston, MA, for 14 years, serving arsenic Clinical Director of the Lank Center for Genitourinary Oncology and arsenic the founding Chair of the Data and Safety Monitoring Committee astatine the Dana-Farber/Harvard Cancer Center.

An adept successful the absorption of GU malignancies, including prostate, renal, bladder and testicular cancers, Dr. Oh has served arsenic the main researcher of aggregate objective trials successful GU cancers. He has authored much than 350 archetypal articles, reviews and publication chapters connected topics relating to prostate, renal, bladder and testicular cancers, and has edited 3 books connected prostate cancer. He has served successful cardinal invited roles for the American Society of Clinical Oncology (ASCO), the American Cancer Society (ACS) and the American Urological Association (AUA), including the Guidelines Committee for Castration-Resistant Prostate Cancer. He was inducted into the prestigious American Society for Clinical Investigation (ASCI) and has been repeatedly selected arsenic a Top Doctor successful New York Magazine, Castle Connolly, Best Doctors and Super Doctors done 2022.

As CMO, Dr. Oh volition enactment to found cardinal fundable translational probe programs that thrust improved objective outcomes for men astatine each stages of prostate cancer. Furthermore, helium volition absorption connected knowing and reducing barriers to the effectual transportation of attraction and caller therapies to men with prostate crab connected a planetary level. He volition pb PCF's efforts to cultivate the adjacent procreation of basic, translational and objective prostate crab researchers by processing acquisition programs, probe awards and philanthropically funded efforts. As a cardinal subordinate of the enactment team, Dr. Oh volition play a cardinal relation successful implementing the strategical imaginativeness of expanding the scope and interaction of PCF.

About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world's starring philanthropic enactment dedicated to backing life-saving prostate crab research. Founded successful 1993 by Mike Milken, PCF has been liable for raising adjacent to $1 billion successful enactment of cutting-edge probe by much than 2,200 probe projects astatine 245 starring crab centers successful 28 countries astir the world. Since PCF's inception, and done its efforts, patients astir the satellite are surviving longer, suffering less complications, and enjoying amended prime of life. PCF is committed to creating a planetary nationalist quadrate for prostate cancer, successful work to our ngo of ending decease and suffering from the disease. Learn much at pcf.org.

MEDIA CONTACT:
Staci L. Vernick
Prostate Cancer Foundation
svernick@pcf.org
press@pcf.org
610-812-6092